DK1239873T3 - Anvendelse af fibrinolytiske metalloproteinaser til terapeutisk behandling af en blodprop - Google Patents

Anvendelse af fibrinolytiske metalloproteinaser til terapeutisk behandling af en blodprop

Info

Publication number
DK1239873T3
DK1239873T3 DK00988099T DK00988099T DK1239873T3 DK 1239873 T3 DK1239873 T3 DK 1239873T3 DK 00988099 T DK00988099 T DK 00988099T DK 00988099 T DK00988099 T DK 00988099T DK 1239873 T3 DK1239873 T3 DK 1239873T3
Authority
DK
Denmark
Prior art keywords
blood clot
therapeutic treatment
fibrinolytic metalloproteinases
fibrinolytic
metalloproteinases
Prior art date
Application number
DK00988099T
Other languages
English (en)
Inventor
Christopher Francis Toombs
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK1239873T3 publication Critical patent/DK1239873T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK00988099T 1999-12-17 2000-12-15 Anvendelse af fibrinolytiske metalloproteinaser til terapeutisk behandling af en blodprop DK1239873T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/466,276 US6455269B1 (en) 1999-12-17 1999-12-17 Method for localized administration of fibrinolytic metalloproteinases
PCT/US2000/034143 WO2001043765A2 (en) 1999-12-17 2000-12-15 Method for localized administration of fibrinolytic metalloproteinases

Publications (1)

Publication Number Publication Date
DK1239873T3 true DK1239873T3 (da) 2005-08-29

Family

ID=23851165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00988099T DK1239873T3 (da) 1999-12-17 2000-12-15 Anvendelse af fibrinolytiske metalloproteinaser til terapeutisk behandling af en blodprop

Country Status (14)

Country Link
US (1) US6455269B1 (da)
EP (2) EP1239873B1 (da)
JP (1) JP2003517020A (da)
AT (1) ATE298585T1 (da)
AU (1) AU784252B2 (da)
CA (1) CA2394613A1 (da)
DE (1) DE60021111T2 (da)
DK (1) DK1239873T3 (da)
ES (1) ES2242655T3 (da)
HK (1) HK1050845B (da)
MX (1) MXPA02006024A (da)
PT (1) PT1239873E (da)
SG (1) SG172474A1 (da)
WO (1) WO2001043765A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261820B1 (en) * 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6440414B1 (en) * 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6455269B1 (en) * 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases
US7033776B2 (en) * 1999-12-17 2006-04-25 Amgen Inc. Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
US20090254062A1 (en) * 2008-04-03 2009-10-08 Mcglothlin Mark W Infusion catheters with slit valves and of simplified construction
US9295393B2 (en) 2012-11-09 2016-03-29 Elwha Llc Embolism deflector
US20140328892A1 (en) * 2013-04-04 2014-11-06 Jullia Y. Lee Use of alfimeprase in the treatment of thrombosis

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447236A (en) 1982-02-05 1984-05-08 Cordis Corporation Infusion catheter system
US4610879A (en) * 1984-01-06 1986-09-09 University Of Southern California Fibrinolytic enzyme from snake vernom
US5000185A (en) 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
ZA889415B (en) 1987-12-18 1989-09-27 Chiron Corp Compositions and method for recombinant production of crotalidus venum fibrolase
WO1990007352A1 (en) 1989-01-04 1990-07-12 Boston Scientific Corporation Angioplasty catheter
US5709676A (en) 1990-02-14 1998-01-20 Alt; Eckhard Synergistic treatment of stenosed blood vessels using shock waves and dissolving medication
US5260060A (en) * 1991-08-09 1993-11-09 University Of Southern California Fibrinolytic enzymes
US5626564A (en) 1995-03-31 1997-05-06 Creighton University Adjustable sideholes catheter
US5830468A (en) 1995-05-17 1998-11-03 The New York Blood Center, Inc. Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase
US5741779A (en) * 1996-05-10 1998-04-21 Xoma Corporation Antithrombotic materials and methods
US5951981A (en) * 1996-12-02 1999-09-14 Diatide, Inc. Thrombolytic agents with antithrombotic activity
US6440414B1 (en) 1999-10-01 2002-08-27 Amgen Inc. Pharmaceutical compositions of fibrinolytic agent
US6261820B1 (en) * 1999-10-01 2001-07-17 Amgen Inc. Fibronolytically active polypeptide
US6455269B1 (en) * 1999-12-17 2002-09-24 Amgen, Inc. Method for localized administration of fibrinolytic metalloproteinases

Also Published As

Publication number Publication date
EP1239873A2 (en) 2002-09-18
PT1239873E (pt) 2005-10-31
EP1239873B1 (en) 2005-06-29
JP2003517020A (ja) 2003-05-20
AU2434601A (en) 2001-06-25
EP1645282A1 (en) 2006-04-12
WO2001043765A2 (en) 2001-06-21
WO2001043765A3 (en) 2002-01-17
SG172474A1 (en) 2011-07-28
ATE298585T1 (de) 2005-07-15
DE60021111T2 (de) 2006-05-11
US6455269B1 (en) 2002-09-24
CA2394613A1 (en) 2001-06-21
HK1050845B (zh) 2005-11-04
ES2242655T3 (es) 2005-11-16
DE60021111D1 (de) 2005-08-04
AU784252B2 (en) 2006-03-02
HK1050845A1 (en) 2003-07-11
MXPA02006024A (es) 2002-12-05

Similar Documents

Publication Publication Date Title
NO20050328L (no) Fremgangsmate for behandling av okklusjon av intravenost kateter ved anvendelse av fibrinolytiske metalloproteinaser
DK0502092T3 (da) Oralt præparat til behandling af inflammatoriske tarmsygdomme
SE9702860D0 (sv) New use
EP1327454A3 (en) Method of treatment with medical agents
DK47089A (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
DK1239873T3 (da) Anvendelse af fibrinolytiske metalloproteinaser til terapeutisk behandling af en blodprop
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DE69125855D1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
NO952137D0 (no) Antitrombosemiddel
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
DK0559145T3 (da) Lægemiddel til truende abort
ATE498305T1 (de) Vermeidung und behandlung von krankheiten, die mit der blutgerinnung in zusammenhang stehen
FI952170A0 (fi) Koagulaatiota edistävää aktiivista ainetta sisältävä stabiili valmisteveren koagulaatiosairauksien hoitamiseksi
EA200500065A1 (ru) Способ лечения закупорки стационарного катетера с использованием фибринолитических металлопротеиназ
WO2003045420A3 (en) Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
RU2004118818A (ru) Способ лечения больных с маточными кровотечениями
SI1239873T1 (sl) Uporaba fibrinoliticnih metaloproteinaz za terapevtsko zdravljenje krvnega strdka
Arndt Treating oedemas: manual lymph drainage
RU2004136304A (ru) Хиноновое терапевтическое средство для лечения заболевания печени
ITVR940023A0 (it) Dispositivo a catetere per il trattamento localizzato di placche e trombi arteriosi e venosi.